Calcipotriol treatment of confluent and reticulated papillomatosis (Gougerot-Carteaud syndrome)

J Eur Acad Dermatol Venereol. 2000 Mar;14(2):131-3. doi: 10.1046/j.1468-3083.2000.00032.x.

Abstract

Gougerot-Carteaud syndrome or confluent and reticulated papillomatosis (CRP), was first described by Gougerot and Carteaud as dermatosis. It is generally considered a rare condition. The eruption consists confluent, flat, brown papules localized primarily to the intermammary and interscapular regions with subsequent spread to the breast and abdomen; at the periphery, the papules spread out forming a pigmented reticulated pattern. At present, the aetiology of CRP remains unknown. The two prominent theories are an abnormal host response to fungi and a keratinization defect. Other hypothesis include photosensitivity, genetic factor, amyloidosis cutis and endocrinopathy.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Calcitriol / analogs & derivatives*
  • Calcitriol / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Humans
  • Male
  • Papilloma / drug therapy*
  • Skin Neoplasms / drug therapy*

Substances

  • Dermatologic Agents
  • calcipotriene
  • Calcitriol